🔎 Trials Near Me

Gara Jalqabaatti › Dhibee Seli Sikiilii › Ohio

Qorannoo klinikaalii Dhibee Seli Sikiilii Ohio keessatti

Qorannoo 22 Dhibee Seli Sikiilii f Ohio keessatti hirmaatuu jiru.

Magaalota Ohio keessatti

Takkalaa qorannoo (Ingiliffa)

A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD)

  • Cincinnati Children's Hospital Medical Center, Cincinnati
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT07187973

A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease

  • Univ Hosp Cleveland Med Ctr, Cleveland
  • Ohio State Univ Wexner Med Ctr, Columbus
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 17-Ful-2026 · NCT06612268

Sickle Cell Disease Biofluid Chip Technology (SCD BioChip)

  • University Hospitals Case Medical Center, Cleveland
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 11-Ful-2026 · NCT02824471

A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease

  • Local Institution - 0028, Cleveland
Namoota walitti qabaa jiraSadarkaa 1/2Hojjettoota fayyaa simatamoo
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 18-Hag-2026 · NCT06481306

ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders

  • Akron Children's Hospital - Showers Center for Cancer & Blood Disorders, Akron
  • Cincinnati Children's Hospital Medical Center, Hemophilia & Thrombosis Center, Cincinnati
  • University of Cincinnati Medical Center Hemophilia Treatment Center, Cincinnati
  • fi 5 dabalataa
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin hundi · Saalaa hunda · Haaromfame 17-Hag-2026 · NCT04398628

Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis

  • University of Cincinnati, Cincinnati
  • The Ohio State University, Columbus
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 14-Hag-2026 · NCT06699849

Integrative Medicine in Pain Management in Sickle Cell Disease, 2.0

  • University of Cincinnati College of Medicine, Cincinnati
Namoota walitti qabaa jiraHojjettoota fayyaa simatamoo
Umuriin 14 hanga 80 · Saalaa hunda · Haaromfame 12-Hag-2026 · NCT06725550

Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)

  • Ohio State University, Columbus
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Hag-2026 · NCT07224360

Gene Correction in Autologous CD34+ Hematopoietic Stem Cells (HbS to HbA) to Treat Severe Sickle Cell Disease

  • Nationwide Children's Hospital, Columbus
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 12 hanga 50 · Saalaa hunda · Haaromfame 02-Ado-2026 · NCT04819841

Hydroxyurea Exposure Limiting Pregnancy and Follow-Up Lactation

  • Cincinnati Children's Hospital Medical Center, Cincinnati
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin hundi · Saalaa hunda · Haaromfame 18-Wax-2026 · NCT04093986

Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease

  • Nationwide Children's Hospital (NT-DMT), Columbus
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 3 hanga 20 · Saalaa hunda · Haaromfame 04-Wax-2026 · NCT06941389

A Socio-ecological Approach for Improving Self-management in Adolescents With SCD

  • Cincinnati Children's Hospital Medical Center, Cincinnati
Namoota walitti qabaa jira
Umuriin 13 hanga 21 · Saalaa hunda · Haaromfame 11-Cam-2026 · NCT06290401

Delivering Patient-Facing Evidence-Based Guidelines Through mHealth to Adults With Sickle Cell Disease

  • The Ohio State University Medical Center, Columbus
Namoota walitti qabaa jira
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 23-Bit-2026 · NCT06919224

Zinc Supplementation in Sickle Cell Disease: A Precursor to the Think Zinc for Bones Trial

  • Cincinnati Children's Hospital, Cincinnati
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 15 hanga 40 · Saalaa hunda · Haaromfame 13-Bit-2026 · NCT06260891

Minimizing Toxicity in HLA-identical Sibling Donor Transplantation for Children With Sickle Cell Disease

  • Nationwide Children's Hospital, Columbus
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 2 hanga 25 · Saalaa hunda · Haaromfame 10-Bit-2026 · NCT03587272

MULTIsite Feasibility of MUSIc Therapy to Address Quality Of Life in Sickle Cell Disease

  • UH Seidman Cancer Center Adult SCD Clinic or UH Rainbow Babies and Children's Hospital Sickle Cell Anemia Center, Cleveland
Namoota walitti qabaa jira
Umuriin 14 fi ol · Saalaa hunda · Haaromfame 29-Ama-2026 · NCT06853158

A Long-term Follow-up Study in Patients Who Received BEAM-101

  • University Hospitals Clevland Medical Center, Cleveland
  • The Clevland Clinic Foundation, Cleveland
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 14 hanga 37 · Saalaa hunda · Haaromfame 28-Ama-2026 · NCT07373639

Verifying Antibodies After Live Immunization Delivery (VALID): A Study of Measles Vaccine Immunogenicity in Children With Sickle Cell Disease

  • Cincinnati Children's Hospital Medical Center, Cincinnati
Namoota walitti qabaa jiraQorannoo ilaalaa
6 Months – 6 Years · Saalaa hunda · Haaromfame 21-Ama-2026 · NCT07356050

Integrative Training Program for Pediatric Sickle Cell Pain

  • Cincinnati Children's Hospital Medical Center, Cincinnati
Namoota walitti qabaa jira
Umuriin 12 hanga 18 · Saalaa hunda · Haaromfame 14-Sad-2025 · NCT06691867

Effectiveness of Nontraditional Hydroxyurea Algorithms: Novel and Clinical Evaluations (ENHANCE)

  • Cincinnati Children's Hospital Medical Center, Cincinnati
Namoota walitti qabaa jiraSadarkaa 4
6 Months · Saalaa hunda · Haaromfame 16-Ful-2025 · NCT07177300

HPC Offered for PRESERVE Expansion

  • The Ohio State University Medical Center, Columbus
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 12 hanga 80 · Saalaa hunda · Haaromfame 28-Hag-2025 · NCT07145411

Recruitment and Engagement in Care to Impact Practice Enhancement (RECIPE) for Sickle Cell Disease

  • Cleveland Clinic, Cleveland
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Wax-2025 · NCT06385886

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.